Eli Lilly acquires Morphic in IBD portfolio expansion [Yahoo! Finance]
Morphic Holding, Inc. (MORF)
Last morphic holding, inc. earnings: 11/12 04:24 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The $3.2bn deal, initially agreed upon in July 2024, has now reached completion and will aid Lilly in enhancing treatment options for individuals suffering from IBD. Morphic has been at the forefront of developing oral integrin treatments for serious chronic ailments. Its asset, MORF-057, is a selective oral small molecule inhibitor of a4ß7 integrin to treat IBD. In October 2023, the US Food and Drug Administration (FDA) approved Lilly's Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), to treat moderately to severely active ulcerative colitis in adults. This asset is the first treatment approved for a type of IBD. Citi served as the exclusive financial advisor to Lilly, with legal counsel provided by Kirkland & Ellis. On Morphic's side, Centerview Partners acted as the exclusive financial advisor, with additional advice from Evercore Group, and Fenwick & West served as legal counsel. Lilly chief scientific officer Daniel Skovronsky stated: “We are
Show less
Read more
Impact Snapshot
Event Time:
MORF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MORF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MORF alerts
High impacting Morphic Holding, Inc. news events
Weekly update
A roundup of the hottest topics
MORF
News
- Eli Lilly Selling $5 Billion of Bonds to Fund Morphic Deal [Yahoo! Finance Canada]Yahoo! Finance Canada
- Eli Lilly Taps Blue-Chip Bond Market to Fund Morphic Acquisition [BNN Bloomberg (Canada)]BNN Bloomberg
- Eli Lilly Taps Blue-Chip Bond Market to Fund Morphic Acquisition [Yahoo! Finance]Yahoo! Finance
- MORF INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Clients to Contact the Firm!Accesswire
- MORF SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Shareholders to Contact the Firm Today!Accesswire
MORF
Earnings
- 4/25/24 - Beat
MORF
Sec Filings
- 8/16/24 - Form S-8
- 8/16/24 - Form S-8
- 8/16/24 - Form S-8
- MORF's page on the SEC website